Trial Profile
A Randomized, Comparative, Controlled Phase III, Multicenter Study of Hexvix Fluorescence Cystoscopy and White Light Cystoscopy in the Detection Of Papillary Bladder Cancer and the Early Recurrence Rate in Patients With Bladder Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2016
Price :
$35
*
At a glance
- Drugs Hexyl aminolevulinate (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Sponsors PhotoCure
- 19 Sep 2014 New trial record
- 19 Sep 2014 New trial record